cis,cis,cis-Di-chlorido-bis-(N4,N4-di-methyl-pyridin-4-amine-κN1)bis-(dimethyl sulfoxide-κS)ruthenium(II).

The structure of the title compound, [RuCl2(C7H10N2)2(C2H6OS)2], has monoclinic (P21/n) symmetry. The Ru-N distances of the coordination compound are influenced by the trans chloride or di-methyl-sulfoxide-κS ligands. The mol-ecular structure exhibits disorder for two of the terminal methyl groups of a dimethyl sulfoxide ligand.